- Home
- PGY vs CDNA Comparison
PGY vs CDNA Comparison
Compare PGY & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PGY
- CDNA
- Stock Information
- Founded
- PGY 2016
- CDNA 1998
- Country
- PGY United States
- CDNA United States
- Employees
- PGY N/A
- CDNA N/A
- Industry
- PGY Finance: Consumer Services
- CDNA Medical Specialities
- Sector
- PGY Finance
- CDNA Health Care
- Exchange
- PGY Nasdaq
- CDNA Nasdaq
- Market Cap
- PGY 863.7M
- CDNA 844.7M
- IPO Year
- PGY N/A
- CDNA 2014
- Fundamental
- Price
- PGY $16.44
- CDNA $16.99
- Analyst Decision
- PGY Strong Buy
- CDNA Buy
- Analyst Count
- PGY 9
- CDNA 6
- Target Price
- PGY $21.61
- CDNA $30.33
- AVG Volume (30 Days)
- PGY 2.6M
- CDNA 1.4M
- Earning Date
- PGY 05-07-2025
- CDNA 04-30-2025
- Dividend Yield
- PGY N/A
- CDNA N/A
- EPS Growth
- PGY N/A
- CDNA N/A
- EPS
- PGY N/A
- CDNA 1.07
- Revenue
- PGY $1,076,961,000.00
- CDNA $346,421,000.00
- Revenue This Year
- PGY $19.84
- CDNA $13.38
- Revenue Next Year
- PGY $13.99
- CDNA $15.33
- P/E Ratio
- PGY N/A
- CDNA $15.81
- Revenue Growth
- PGY 23.69
- CDNA 25.92
- 52 Week Low
- PGY $8.20
- CDNA $12.90
- 52 Week High
- PGY $19.20
- CDNA $34.84
- Technical
- Relative Strength Index (RSI)
- PGY 66.97
- CDNA 49.78
- Support Level
- PGY $13.85
- CDNA $16.57
- Resistance Level
- PGY $17.44
- CDNA $18.02
- Average True Range (ATR)
- PGY 0.80
- CDNA 0.77
- MACD
- PGY 0.18
- CDNA 0.14
- Stochastic Oscillator
- PGY 73.33
- CDNA 59.45
About PGY Pagaya Technologies Ltd.
Pagaya Technologies Ltd is a financial technology company working to reshape the lending marketplace by using machine learning, data analytics, and sophisticated AI-driven credit and analysis technology. It was built to provide a comprehensive solution to enable the credit industry to deliver customers a positive experience while simultaneously enhancing the broader credit ecosystem. Its proprietary API seamlessly integrates into its next-gen infrastructure network of partners to deliver a premium customer user experience and greater access to credit. The company generates majority of its revenue from United States.
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.